Cantitate/Preț
Produs

Non-Hodgkin Lymphoma: Prognostic Factors and Targets: Cancer Drug Discovery and Development

Editat de Peter J. Quesenberry, Jorge J. Castillo
en Limba Engleză Paperback – 25 iun 2015
This book will be the first that focuses on solely on model organisms for lymphoma. It's editors are internationally recognized in the field.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 109516 lei  43-57 zile
  Springer – 25 iun 2015 109516 lei  43-57 zile
Hardback (1) 110395 lei  43-57 zile
  Springer – 28 ian 2013 110395 lei  43-57 zile

Din seria Cancer Drug Discovery and Development

Preț: 109516 lei

Preț vechi: 115281 lei
-5% Nou

Puncte Express: 1643

Preț estimativ în valută:
20958 21748$ 17518£

Carte tipărită la comandă

Livrare economică 17-31 martie

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781489994196
ISBN-10: 148999419X
Pagini: 312
Ilustrații: VI, 304 p.
Dimensiuni: 155 x 235 x 16 mm
Greutate: 0.44 kg
Ediția:2013
Editura: Springer
Colecția Humana
Seria Cancer Drug Discovery and Development

Locul publicării:New York, NY, United States

Public țintă

Research

Cuprins

Cancer Stem Cells: A Matter of Perspective.- B and T-cell development.- HIV lymphomagenesis.- Epstein-Barr Virus Lymphomagenesis and Therapeutic Targets.- Antigen driven lymphomagenesis.- Pre-clinical lymphoma models.- Prognostic factors in B-cell lymphoma.- Prognostic factors in T-cell lymphoma.- Prognostic factors in HIV-associated lymphoma.- Future directions on the treatment of aggressive non-Hodgkin lymphoma.- New monoclonal antibodies for indolent non-Hodgkin lymphomas.- Current therapies for T-cell lymphoma.- Stem Cell Transplantation for lymphoma.- Autologous stem cell transplantation in non-Hodgkin lymphoma.- The role of Stem Cell Transplantation for HIV-associated lymphoma.- Stem Cell Transplantation for T-cell lymphoma.- Index.

Textul de pe ultima copertă

Recent developments in the therapy of non-Hodgkin lymphoma have improved response and survival rates in patients with these conditions. This book is focused on the biology, prognostic factors and novel targets of non-Hodgkin lymphoma. We believe that understanding the pathophysiology of non-Hodgkin lymphoma provides a mean to improve its risk-stratification and treatment. This book is intended for medical and healthcare professionals involved in the research and clinical care of patients with non-Hodgkin lymphoma.

Caracteristici

This book will be the first that focuses on solely on model organisms for lymphoma The editor Peter J. Quesenberry is internationally recognized in the field In-depth discussion of lymphoma models and their prognostic factors Includes supplementary material: sn.pub/extras